Theme:
BABE 2023
It’s an enormous pleasure and feel respected to organize 14th Annual Congress on Bioavailability and Bioequivalence scheduled during July 13-14, 2023 Dubai, UAE.
Bioequivalence 2023 is designed with the keynote sessions, session lectures, poster presentations, presentations from the young researchers, panel Discussions, and the B2B meetings with world-renowned speakers from the stream of clinical and pharmaceutical sciences. It provides the best platform for the researchers to the researchers all over globe to introduce themselves to the innovative world with their unique research. It’s an open forum to discuss new researches and the challenges faced during the BA/BE studies, manufacturing the generic drugs and their effect on the public health.
Who to attend?
- Pharmacist Allied Health Personnel
- Bioinformatics
- Neurochemistry
- Pharmacologists in Clinical and Cellular Practice Neurologist
- Biotechnology Experts
- Neuropharmacology
- Neurophysiologist
- Neuropsychologist
- Neuroradiology
- Psychobiologist
- Medical Psychologist
- Pharmaceutical Formulations Used by Psychiatrists
- Manufacturing
- delivery of drugs
- Bioavailability
- Drug Evaluation
- Delivery Equipment
Track 1: Bioavailability
A drug's total bioavailability is typically less than one when administered via an extravascular route. A variety of physiological factors reduce the availability of medicines before they enter the systemic circulation. Absorption will be affected whether the medication is taken with or without food. Other medications taken concurrently may alter absorption and first-pass metabolism, intestinal motility may alter how the medication is terminated, and intestinal micro flora may influence how much of the medication is chemically humiliated. There will also be a conclusion regarding conditions that impair the digestive system or the liver's function..
- Hepatic first-pass effect
- Factors affecting bioavailability
- Route of administration
- Relative bioavailability
- Absolute bioavailability
Track 2: Bioequivalence
The Cost as a result, when administered at the same molar dose under the atmosphere, two medications with the same active component, such as a brand-name medication and its generic equivalent, or two distinct dosage forms of the same medication, such as an oral suspension and a tablet, have homogenous bioavailability and produce the same result at the site of physiological activity. As a result, their outcomes should be nearly identical. In vitro Bioequivalence
- Clinical trial formulations
- Therapeutic index
- Generic drugs
- Bioequivalence of endogenous substances
Track 3: Recent biosimilars strategies
Biosimilars square measure medications that claim to possess no clinical variability in purity, potency, and safety. These medications have a big impact on folks with a good vary of unhealthful and grievous diseases, as well as rheumatism, degenerative disorder, leukaemia, lymphomas, internal organ myopathies, and numerous oncogenic cancers.
- Analytical techniques
- Cancer therapies
- Cardiovascular therapies
- Diabetes therapies
- Cancer therapies
- Biosimilars: Regulatory Approach
Track 4: Drug Security
Scope of Pharmacovigilance Drug Safety is extraordinarily unbiased. an expert path that probably involves operating in each permanent and temporary positions. reckoning on the amount of exposure earned, a career in drug safety could lean towards disposal or a additional technical path involving risk management, detection, and medicine.
Track 5: Factors Affecting Bioavailability
Inherent no uniformity has Excipients of the many medications, as well as carbamazepine, show polymorphism. completely different polymorphs dissolve otherwise. exploitation Associate in Nursing amphiphilic mixture, dilute and dissolve Endogeneous, amphiphiles. they're phospholipid, monooleins, and gall salts. exogenous amphiphiles and Ionization vary
Track 6: Clinical Pharmacology and Therapeutics
Clinical trials square measure analysis comes conducted on people with the goal of estimating a medicative, surgical, and behavioral intervention. Clinical trials square measure analysis comes administrated on people with the goal of evaluating a therapeutic, surgical, or behavioral intervention. Clinical trials square measure intensive human testing investigations supposed to measure the effectiveness of a medicative, surgical, and behavioral intervention.
- In Vitro and In Vivo investigations,
- Clinical Study Designs,
- Clinical Trial Management,
- Clinical Research Phase Studies,
- Re-Clinical Research/Trial,
- Bioequivalence Protocols: In Vitro-In Vivo Correlation
Track 7: Pharmaceutical Formulations
The expression often functions in an exceedingly means that takes in several indefinite quantity forms. The indefinite quantity conformation is that the pharmaceutical drug out come back as marketed to be used with a unrelated mixture of active substance and inactive parts. it's a capsule shell testimonial into a particular dose. Pharmaceutical statement is that the multistep operation wherever the active drug is mixed with all alternative parts by seeable of the factors of polymorphism, particle size, pH, and solubility and becomes the ultimate useful healthful productSolid Dosage Form
- Topical Dosage form
- Parenteral Dosage form
- Immediate-Release Products
- Modified-Release Products
Track 8: Significance of BA/BE Studies
Bioequivalence studies ar necessary for the expansion of a pharmaceutical compound within the pharmaceutical trade. Their reasoning is that the observe of pharmacodynamics and pharmacokinetic parameters once the commanding of tested medicine Bioequivalence could be a word in pharmacological medicine accustomed assess the design forward to in vivo biological equivalence of 2 proprietary production of a drug.
- Novel Drug Delivery Systems- BA/BE approach
- Generic drugs: Current claims and future directions
- BA/BE Studies for Immediate-Release Solid Oral Dosage Forms
- Bioequivalence analysis of highly variable drugs
- Bioavailability Study for cancer drugs
- Food-effect Bioavailability and fed Bioequivalence studies
Track 9: Drug Metabolism
It is accustomed specific the biotransformation of pharmaceutical substances within the body. so they will be terminate additional merely. The mass of metabolic processes that needed medication takes place within the liver, because the enzymes that facilitate the reactions square measure reduced. Most medication should flow through the liver; this is often the first web site of drug metabolism. Once within the liver, enzymes transforms prod rugs into active metabolites and convert active medication into inactive forms
- Phase 1 metabolism of drug: P450 (CYP450)Enzyme
- Phase I vs. Phase II Metabolism
- Food/herbal remedies- drug interaction
- Drug Efficacy and toxicity
- Plasma Concentrations and Drug Effects
Track 10: Trials in Clinical Pharmacology, Therapeutics, and Medicine
Clinical medical specialty lies at the nexus of advanced medication medical care for human unwellness and elementary medical specialty. Clinical drugs|materia medica|medicine|medical specialty} has become essential for the event of surgery moreover as for the right understanding and use of recent medicine as a results of pharmacotherapy's dominance in medicine nowadays.Pre-clinical research/trial
- In Vitro and In Vivo investigations
- Clinical Study Designs
- Clinical Trial Management
- Clinical Research Phase Studies
- Bioequivalence Protocols: In vitro-In vivo Correlation
Track 11: Requirements for Regulatory Bioequivalence
The bioequivalence for oral drug is decided in contrast the relative bioavailability of the emblem drug compared to the drug. Food impact bioavailability area unit ordinarily conducted for brand spanking new medication and drug impact throughout the investigational new drug (IND) part to assess the results of food on the speed and proportions of engrossment of a drug once the drug product is management shortly when a meal fed conditions, as compared to commanding underneath diet conditions.
- WHO Approaches
- FDA Approach and regulations
- TGA and risk management approach
- Food-Effect Bioavailability and Fed Bioequivalence Studies
- European Guidelines
Track 12: Clinical Research Vs Clinical Trails
Clinical trials ar investigation studies ar perform in folks that ar aimed estimate a medical, surgical and behavioral interposition Clinical trials ar analysis studies performed in folks that ar aimed value, a medical, surgical, and behavioral intervention. Clinical trials ar testing studies thorough in folks that ar aimed toward estimate a medical, surgical and behavioral intervention.
- Pre-clinical research/trial
- Clinical Trial Management
- Clinical research phase studies
- In Vitro and In Vivo studies
- Clinical Study Designs
- Bioequivalence Protocols: In vitro-In vivo correlation
Track 13: Pharmaceutical Metabolization
It is wont to describe however pharmacologic medicine ar remodeled by the body. so it'll be easier to finish them. because the enzymes that speed up the reactions ar diminished, an oversized variety of metabolic processes that needed medications turn up within the liver. The liver is that the main website of drug metabolism and should be crossed by the bulk of medicines. Once within the liver, enzymes modification pre-medicated substances into active metabolites and alter already-used substances into inactive ones.
- Phase I vs. Phase II Metabolism
- Drug Efficacy and Toxicity
- Drug Effects and Plasma Concentrations
- Food/herbal remedies-drug interactions
Track 14: Meaning of BA/BE Studies
A life product is AN entity created from living organisms, like human, yeast, animals, or microorganisms, and acting as a therapeutic medication or vaccination. Proteins and their constituent amino acids, sugars for carbohydrates, and nucleic acids for polymer compose biologics, that ar versatile. to boot, biologics could also be tissues or cells employed in transplants. The Biosimilars could be a healthful medication that's structurally like a life whole however is never mentioned in relevancy biologics.
- Analytical techniques
- Cancer therapies
- Cardiovascular therapies
- Diabetes therapies
- Cancer therapies
- Biosimilars: Regulatory Approach
Track 15: Drug Design and Development Challenges
Animal models usually area unit unable to accurately reproduce associate unwellness or illness. enlarged clinical phenotyping and endotyping helps address problems associated with the patient population's heterogeneousness. Target identification and validation area unit improved as human information power is placed with additional attention.
- Topical Drug Development
- Computer-Aided Drug Design
- Rational Drug Design Approach
- Novel Approach
- Genetics in Drug Development
Track 16: Study Designs
The design of any study is a lot of relevant. Than analysing the result, as a badly designed study cannot in any respect be recovered, wherever as a badly look over study may be readdress, to succeed in a worthy. Rather, the layout of the study worthy however the information bring about to may be best inspects. The scientific morality of the study and therefore the trustiness of the information from the study those in essence rely upon the study style. Study styles area unit set of technique and build accustomed collect and analyse information in study. principally speaking and there area unit a pair of forms of study designs: analytical studies and descriptive studies.
Track 17: Recent approaches to Biosimilars
The design of any study is a lot of relevant. Than analysing the end result, as a badly designed study cannot in the slightest degree be recovered, wherever as a badly look over study may be readdress, to achieve a worthy. Rather, the layout of the study worthy however the info produce to may be best inspects. The scientific morality of the study and therefore the trait of the info from the study those in essence rely upon the study style. Study styles ar set of technique and build wont to collect and analyse information in study. principally speaking and there ar a pair of sorts of study designs: analytical studies and descriptive studies.
Track 18: BCS & IVIVC Based Biowaivers
It is a substructure for compartment, drug material supported its solubility and assimilatory it's a drug development device to elucidate ‘bio waiver’ in concurrence with the dissolution of the drug product. (BCS) primarily based bio releases The term bio waiver is request to a regulative drug approval method once the written account is settle for supported conformation of equivalence aside from in vivo bioequivalence check
- BCS bio waivers
- Preclinical and clinical testing for oral drug delivery
- In vitro preclinical ADME/BCS testing
- In vitro drug product research
- Dissolution testing in drug formulation
Track 19: Bio waivers based on BCS and IVIVC
Based on the medicative material's solubility and spongy properties, it is a compartment substructure. it's a tool utilized in the event of prescription drugs to explain "bio waiver" at the same time with the medication product's dissolution. Bio waivers supported the BCS once the written record is accepted supported proof of equivalence apart from Associate in Nursing in vivo bioequivalence take a look at, it's necessary to request a bio release from the restrictive drug approval method.BCS bio waivers
- Dissolution testing in drug formulation
- In vitro preclinical ADME/BCS testing
- In vitro drug product research
- Preclinical and clinical testing for oral medication delivery
Track 20: Biosimilars
A Biosimilars may be a life medical product extremely alike to a different already settle for biological medication. within he EU, Biosimilars area unit approved per constant level of pharmaceutical quality, safety and effectuality that request to all or any biological medicines.
- Biosimilars Development
- Biosimilars Pipeline
- Biosimilars in Therapeutics
- Biosimilars Pipeline
Conference Highlights
- Bioavailability
- Bioequivalence
- Recent biosimilars strategies
- Drug Security
- Factors Affecting Bioavailability
- Clinical Pharmacology and Therapeutics
- Pharmaceutical Formulations
- Significance of BA/BE Studies
- Drug Metabolism
- Trials in Clinical Pharmacology, Therapeutics, and Medicine
- Requirements for Regulatory Bioequivalence
- Clinical Research Vs Clinical Trails
- Pharmaceutical Metabolization
- Meaning of BA/BE Studies
- Drug Design and Development Challenges
- Study Designs
- Recent approaches to Biosimilars
- BCS & IVIVC Based Biowaivers
- Bio waivers based on BCS and IVIVC
- Biosimilars
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
Conference Date | July 13-14, 2023 | ||
Sponsors & Exhibitors |
|
||
Speaker Opportunity Closed | |||
Poster Opportunity Closed | Click Here to View |
Useful Links
Special Issues
All accepted abstracts will be published in respective Our International Journals.
Abstracts will be provided with Digital Object Identifier by